In this role, you will develop, optimize, and implement sequencing-based analytical methods supporting mRNA-based vaccines, therapeutics, and emerging nucleic-acid modalities at various stages within Analytical Development. You will apply strong molecular biology and sequencing expertise across next-generation sequencing (NGS), Oxford Nanopore Technologies (ONT) long-read sequencing, Illumina short-read sequencing, and related emerging technologies to characterize DNA, RNA, and mRNA products, assess critical quality attributes, confirm identity and sequence integrity, and detect product- and process-related impurities and variants. Success in this role requires hands-on scientific strength in assay and workflow development, a strong understanding of sequencing fundamentals and nucleic-acid sample preparation, effective partnership with Moderna bioinformatics, and cross-functional collaboration. You will own defined method-development workstreams, build robust and phase-appropriate analytical procedures, and help establish sequencing platform methods that can be leveraged across programs and ultimately transitioned into the broader analytical and Quality Control network.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree